234 related articles for article (PubMed ID: 6627892)
1. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
[No Abstract] [Full Text] [Related]
2. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
[No Abstract] [Full Text] [Related]
3. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
Zecchi P; Bellocci F; Santarelli P; Iannarelli M
Clin Ter; 1986 Jan; 116(1):19-24. PubMed ID: 2870837
[No Abstract] [Full Text] [Related]
4. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide].
Gragnoli G; Righi GA; Turchetti V; Mondillo S; Kristodhullu A
Minerva Med; 1984 Nov; 75(43):2609-15. PubMed ID: 6392936
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.
Am J Cardiol; 1983 Dec; 52(10):1230-7. PubMed ID: 6359851
[TBL] [Abstract][Full Text] [Related]
6. [Nadolol + bendroflumethiazide in a fixed combination and in sequential administration. Experimental research on antihypertensive efficacy and tolerability].
Del Re ML; Ricci A; Abate G
Clin Ter; 1986 Mar; 116(5):385-90. PubMed ID: 2871962
[No Abstract] [Full Text] [Related]
7. A double-blind study of Inderex in the treatment of essential hypertension.
Crowe PF; Finnegan OC; Russell CJ; Varma MP
Br J Clin Pract; 1987 Oct; 41(10):967-70. PubMed ID: 3333146
[No Abstract] [Full Text] [Related]
8. [Antihypertensive effect of metoprolol in essential hypertension].
Rodríguez Rodríguez FJ; Petersen Guitarte G; Paumard Fraguas A; López-Vidriero E; Franco Manera R
Med Clin (Barc); 1983 Mar; 80(8):358-61. PubMed ID: 6855321
[No Abstract] [Full Text] [Related]
9. [Comparison of nadolol and chlorthalidone in hypertensive subjects resistant to therapy with only captopril].
De Cesaris R; Ranieri G; Chiarappa R; Balestrazzi M; Antoncecchi E
Clin Ter; 1986 Mar; 116(6):465-71. PubMed ID: 3522061
[No Abstract] [Full Text] [Related]
10. [Our experience on the clinical use of nadolol].
Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
[No Abstract] [Full Text] [Related]
11. [Nadolol, a long-term acting beta blocking agent, in the treatment of essential arterial hypertension].
Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765278
[No Abstract] [Full Text] [Related]
12. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
Cervera J; Torres-Zamora M; Gutiérrez-Carreño R; Fierro M; Schaeffer L; Landa L
Arch Invest Med (Mex); 1983; 14(4):331-41. PubMed ID: 6678555
[No Abstract] [Full Text] [Related]
13. [Multicenter study of atenolol, combined with hydralazine and bendroflumethiazide in the treatment of essential, mild, and severe, arterial hypertension].
Ferreira IJ; Escosa L; Casasnovas JA; Barrios SJ; Marcos JM; Pardell H; Navarro A; de la Fuente V
An Med Interna; 1989 Mar; 6(3):128-32. PubMed ID: 2491186
[TBL] [Abstract][Full Text] [Related]
14. [Combined treatment of arterial hypertension. Comparison of a beta-blocker plus a saluretic combination with beta-blocker].
Rodatz KW; Hörder MH
MMW Munch Med Wochenschr; 1983 Feb; 125(7):136-8. PubMed ID: 6133217
[No Abstract] [Full Text] [Related]
15. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Freis ED
Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
[TBL] [Abstract][Full Text] [Related]
16. [Beta-blockers and arterial hypertension: comparison between nadolol and propranolol].
Abate G; Polimeni RM; Di Peppe MC; Guarino F; Troja C; Marisi F; Cerritelli E; Brillante C; De Angelis M
Clin Ter; 1982 Aug; 102(3):283-291. PubMed ID: 7140182
[No Abstract] [Full Text] [Related]
17. [Dioodobufenine in the treatment of essential arterial hypertension].
Paladini G; Sgoifo E
Minerva Cardioangiol; 1980 May; 28(5):303-8. PubMed ID: 7207819
[No Abstract] [Full Text] [Related]
18. [Ambulatory treatment of hypertension with the beta-blockader corgard (nadolol)].
Charyev KhE; Erina EV; Iurenev AP; Lediasheva GA
Ter Arkh; 1984; 56(11):43-6. PubMed ID: 6523386
[TBL] [Abstract][Full Text] [Related]
19. [Celiprolol efficacy and tolerance in the treatment of arterial hypertension].
Lobos Bejarano JM; Granados Menéndez MI; del Valle González J; Bravo Juega P
An Med Interna; 1991 Jan; 8(1):52-3. PubMed ID: 1680475
[No Abstract] [Full Text] [Related]
20. The mild hypertension dilemma: results of the British MRC trial.
Miall WE
J Clin Hypertens; 1986 Sep; 2(3 Suppl):12S-21S. PubMed ID: 3098929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
